AI Article Synopsis

Article Abstract

We have developed an immunization platform which combines heat shock proteins (Hsp) with protein antigens, such as viral or cancer targets, into a single recombinant fusion protein. Pre-clinical data demonstrate the ability of Hsp fusion proteins to induce antigen-specific cytotoxic T lymphocytes, Type 1 cytokines and anti-tumour immunity. One Hsp fusion protein, HspE7, is now in clinical development for therapy of diseases caused by human papillomavirus (HPV). HPV infection is associated with development of proliferative lesions (papillomas or warts) as well as malignant lesions (anogenital dysplasia and cancer). HspE7 has been shown in efficacy trials to be active against genital warts and anal dysplasia, and a trial is underway in another HPV indication, recurrent respiratory papillomatosis. Having observed therapeutic activity for our lead product HspE7 in humans, we are currently developing Hsp fusion proteins as therapeutic vaccines for other chronic viral infections. Potential targets include hepatitis B, herpes simplex, hepatitis C, and human immunodeficiency virus.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hsp fusion
12
heat shock
8
shock proteins
8
chronic viral
8
fusion protein
8
fusion proteins
8
coval fusions
4
fusions therapeutic
4
therapeutic vaccine
4
vaccine platform
4

Similar Publications

Article Synopsis
  • A micro-robot is introduced for inspecting the internal defects of large transformers, overcoming challenges in visually detecting carbon traces within a metal-enclosed structure.
  • The proposed HSP-UNet architecture enhances the segmentation of carbon traces by integrating adaptive histogram equalization, a new attention module, and a pixel shuffle up-sampling technique.
  • HSP-UNet outperforms existing segmentation methods (like UNet and UNeXt) significantly, achieving improvements in metrics like Mean Intersection over Union and Pixel Accuracy for various carbon trace types.
View Article and Find Full Text PDF

Heat shock protein 16-kDa (HSP 16-kDa) is essential for the survival of () during the latent period; hence, a peptide-MHC presentation of HSP 16-kDa could be a potential diagnostic and therapeutic target for latent tuberculosis (LTB). This study aimed to generate a TCR-like single-domain antibody (sDAb)-human IgG1 antibody and subsequently investigate its diagnostic and therapeutic potential in LTB, utilizing a model cell presenting the target peptide. A previously generated TCR-like sDAB that can bind to HSP 16-kDa was first fused to a human IgG1 Fc-receptor via a linker.

View Article and Find Full Text PDF

Novel Strategy for In Vitro Validation of Babesia orientalis Heat Shock Proteins Chaperone Activity and Thermostability.

Acta Parasitol

March 2024

State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, Hubei, People's Republic of China.

Background: Babesia orientalis is an intra-erythrocytic protozoan parasite that causes babesiosis in water buffalo. The genome of B. orientalis has been reported and various genes have been accurately annotated, including heat shock proteins (HSP).

View Article and Find Full Text PDF

Insight on thermal stress response of demosponge Chondrosia reniformis (Nardo, 1847).

Sci Total Environ

February 2024

Laboratory of Genetics, Biodiversity, and Bioresources Valorization (LR11ES41), Higher Institute of Biotechnology of Monastir, University of Monastir, Monastir 5000, Tunisia. Electronic address:

Global warming has led to an increase in extreme weather and climate phenomena, including floods and heatwaves. Marine heatwaves have frightening consequences for coastal benthic communities around the world. Each species exhibits a natural range of thermal tolerance and responds to temperature variations through behavioral, physiological, biochemical, and molecular adjustments.

View Article and Find Full Text PDF
Article Synopsis
  • Heat shock proteins (HSPs) can boost immune responses, and this study specifically evaluates fragments of Hsp70 and Hsp27 as vaccine adjuvants to enhance immunity against HIV-1 Nef.
  • Researchers created nanoparticles to deliver DNA constructs encoding these HSPs fused with Nef, and assessed their effectiveness in both lab cultures and live mice.
  • Results showed that the C-Hsp70 fragment was particularly effective in promoting strong immune responses, including higher antibody and cytokine production, making it a promising candidate for improving HIV-1 vaccines.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!